A recent report has suggested that common genetic variation in genes encoding for centrosome pathway components (excluding AURKA and HMMR) may frequently influence risk of breast cancer and, notably, includes variants in TACC3–a proposed HMMR homolog [63]–TUBG1, and TPX2 loci [64]. The gene discussed is TPX2; the disease is breast cancer.